Show simple item record

dc.contributor.authorJuma, BW
dc.contributor.authorWaiyaki, PG
dc.contributor.authorBulimo, WD
dc.contributor.authorWurapa, EK
dc.contributor.authorMutugi, MM
dc.contributor.author1, S Kariuki
dc.date.accessioned2015-07-17T06:46:37Z
dc.date.available2015-07-17T06:46:37Z
dc.date.issued2014
dc.identifier.urihttps://www.uonbi.ac.ke/wallacebulimo/files/molecular_detection_of_enterotoxigenic.pdf
dc.identifier.urihttp://hdl.handle.net/11295/88048
dc.description.abstractIntroduction: Enterotoxigenic Escherichia coli (ETEC) is known for its public health importance globally, however, a protective vaccine is yet to be developed. Information regarding the immunology of ETEC’s virulence proteins that can lead to studies on vaccine development such as the heat stable toxins (ST), heat-labile toxin (LT), colonization factors (CFs) and coli surface antigens (CS) from many regions of the world is available. In Kenya, specific CFAs and CS have not been adequately characterized. This study looked at the surface antigens of diarrhoeagenic E. coli in search of indicators for vaccine materials development. Methodology: Multiplex polymerase chain reaction assay were employed to detect diarrhoeagenic E. coli pathotypes and enteroxigenic Escherichia coli surface antigens/ colonization factors antigens from 300 patients in Machakos Hospital, Kenya. Results: Enteroaggrigative Escherichia coli was the most predominant (13.7%) followed by ETEC (11%), Enteroinvesive E. coli (8.3%) and Enteropathogenic E. coli (4.3%). Among the colonization factor antigens, CFAI was detected at 25 (23%), CS1, CSII 2(1.9%), CS3 1(0.9%), CS6 13(12%), CS7 2 (1.9%), CS12 1(0.9%), CS19 11 (10.25%) and those without colonization factor 37 (34.3%). Conclusions: ETEC isolates carrying ST or STLT toxins had more recoverable CFs than those with LT alone (P<0.05). The CS6 is increasing and CS19 was detected for the first time in Kenya and shown to be persistent adhesins. These may be further investigated as possible candidates for the formulation of a novel vaccine for the prevention of diarrhoea in Kenya and the regionen_US
dc.language.isoenen_US
dc.publisherUniversity of Nairobien_US
dc.titleMolecular detection of enterotoxigenic escherichia coli surface antigens from patients in Machakos district hospital, Kenyaen_US
dc.typeArticleen_US
dc.type.materialen_USen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record